A hypothesis of couplet molecules and couplet cells in gastric function and an association with 
                   by unknown
DEBATE Open Access
A hypothesis of couplet molecules and
couplet cells in gastric function and an
association with Helicobacter pylori
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Abstract
Background: Gastrin, from G-cells, and histamine, from enterochromaffin-like (ECL) cells, are two of the hormones
that regulate gastric activity.
Discussion: It is proposed that the G-cells and the ECL cells are coupled by the couplet molecules gastrin and
histamine and by a prior asymmetrical cell division. The gastrin (from G-cells) stimulates the ECL cells to produce
and secrete histamine while, in a reciprocal way, this histamine (from ECL cells), stimulates the G-cells to produce
and secrete gastrin. These molecules would also stimulate cell division – the gastrin would stimulate cell division of
ECL cells while histamine would stimulate that of G-cells. A chemical complex of gastrin and histamine is
postulated as is also the asymmetric cell divisions of precursor cells to produce the coupled G-cells and ECL cells.
Conclusion: There is sufficient evidence to support the feasibility of the model in general, but more direct
experimental evidence is required to validate the model as applied here to gastric function.
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Background
Gastric activity is regulated by various hormones includ-
ing gastrin and histamine. The hypothesis offered here
will tie together the activities of these two hormones and
the specific cells that produce them, namely G-cells and
enterochromaffin-like (ECL) cells, respectively.
Gastrin is a hormone that is secreted from G-cells
which are mainly in the antrum of the stomach and the
duodenum, and it stimulates acid secretion by the par-
ietal cells. There are a number of forms of gastrin in-
cluding ones with 14, 17 or 34 amino acids, perhaps
sulphated, amidated or with an additional glycine at the
C-terminus. There are a number of potential receptors
for gastrin and its related molecules – cholecystokinin
(CCK) A, B and C receptors plus other high-affinity re-
ceptors. Of these, CCKB binds sulphated gastrin; CCKC
is a low-affinity gastrin binding protein; and there are
high-affinity receptors selective particularly for amidated
gastrin [1]. The major gastrin receptor (CCKB) is a G-
protein coupled receptor and is also found in the CNS.
Histamine also acts as a hormone and neurotransmit-
ter. It is produced by enterochromaffin-like (ECL) cells
and exerts hormonal control of gastric acidity. It is also
produced by mast cells and basophils and triggers an in-
flammatory response to foreign pathogens. There are
four specific types of histamine receptors (H1, H2, H3,
H4) and they are 7-transmembrane G-protein coupled
receptors [2]. The H2 receptor functions to stimulate
gastric acid production by parietal cells.
The model proposed here is an example of a more
generic model that has already been proposed as a basis
towards an understanding of multicellular organisation
and cellular interactions within tissue cells [3]. The base
of this model is an initial asymmetric cell division of pre-
cursor cells to produce two cell types which share inher-
ent specific cellular communications. Symmetric cell
divisions of the two types of cells will produce a mixed
cluster of cells with an equilibrium of metabolic pro-
cesses maintained by control of individual cell activity
and of cell numbers. The cell communications are recip-
rocal and one of the couplet molecules, produced by one
cell type, stimulates the growth of the other cell type via
a cell receptor. The type and number of cell divisions
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will be controlled by the levels of the individual mole-
cules and by the level of the complex formed by the
couplet molecules. This generic model has been de-
scribed with specific reference to various diseases in-
cluding that associated with Helicobacter pylori [3].
The model has already been further elaborated on for
insulin and glucagon as couplet molecules, derived from
the beta- and alpha-cells of the pancreas [4]. The model
is here specifically interpreted to the G-cells and the
neighbouring ECL cells and their stimulation by hista-
mine and gastrin respectively where these coupled mole-
cules are produced by the couplet cells reciprocally. The
model requires that a special molecule (a Trefone) will
be both a proliferator and a secretagogue of the same
cell type. For example, gastrin may be such a molecule
as it is a potent gastrointestinal trophic agent acting as a
growth factor to induce cell proliferation and is also a
histamine secretory agent [5].
Discussion
Evidence required to support the model in gastric
function
The model proposed in reference [3] has Couplet mole-
cules (“Trefones”) produced by couplet Cells and is re-
ferred to as the CTC model. The couplet cells produced
by the asymmetric cell division of a precursor cell are re-
ferred to as the a-Cell and the i-Cell. Gastrin and hista-
mine would be Trefone couplets - two interacting, cell-
stimulating molecules produced by couplet cells that
form a complex described in the generic model as a
“Trefone Couplet Complex” This couplet complex
(TCC), together with the individual molecules, control
cell division. The G-Cell and the ECL cell are the cell
couplets and, arbitrarily in this proposal, the G-cell is
the a-Cell which produces gastrin (aT) and the ECL cell
is the i-Cell which produces histamine (iT). Reciprocal
receptors are indicated in Fig. 1.
Thus for the proposed couplet cells (G-cells and ECL
cells) with a molecular couplet of gastrin and histamine,
the following would be expected:-
(1). Gastrin binds histamine to form a complex.
(2). (i). G-cells have receptors for histamine.
(ii). Histamine normally stimulates proliferation of
G-cells.
(iii). Histamine inhibits proliferation of G-cells
when both histamine and gastrin are high.
(iv). Histamine stimulates production/secretion of
gastrin by G-cells.
(3). (i). ECL cells have receptors for gastrin.
(ii). Gastrin normally stimulates proliferation of
ECL cells.
(iii). Gastrin inhibits proliferation of ECL cells
when both gastrin and histamine are high.
(iv). Gastrin stimulates production/secretion of
histamine by ECL cells.
(4). G-cells and ECL cells each have a receptor for the
gastrin: histamine complex.
Evidence to support this model is offered.
The evidence:-
(1) Gastrin (GAS) binds Histamine (HTM)
There is no evidence for this, known to be recorded.
Were studies to be conducted to assess this potential
binding, all of the five active forms of gastrin would need
to be considered to discover the actual couplet of hista-
mine (ie. the Trefone). Progastrin, the C-terminal Gly-
extended gastrins (G34-Gly and G17-Gly) and the C-
terminal amidated gastrins (G34 and G17), all have some
biological activity [6].
(2) (i) G-Cells have receptors for Histamine
Rabbit G-cells have HTM H2-receptors [7] and the
cells release gastrin upon HTM stimulation. This
receptor would function in a different way in G-cells
compared to H2-receptors in parietal cells where
the receptor, with HTM bound, stimulates acid
production.
(ii) Histamine stimulates proliferation of G-Cells
HTM stimulates proliferation of a human gastric
adenocarcinoma subline (MKN45G) which itself pro-
duces GAS and which therefore could be a model for G-
Fig. 1 The Simple Interaction of a G-Cell and an ECL Cell. The reciprocal interactions of a G-Cell and an ECL Cell (GC and ECLC) are illustrated. The
stimulatory effects of Gastrin (GAS) and Histamine (HTM) occur by acting via cell membrane receptors GASR and HTMR
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cells [8]. HTM also increased the proliferation of grafted
MKN45G tumour tissue in nude mice [8]. HTM it is
also known to be a proliferative stimulant for some
other cells (eg. airway smooth muscle cells [9], cul-
tured rat thymic epithelium cells [10] and a Leydig
cancer cell line [11]).
(iii) Histamine inhibits proliferation of G-Cells
HTM is not known to be an inhibitor of G-cells but it
is an inhibitor for other cells (eg. colorectal [12], pancre-
atic carcinoma cells [13]). For the latter, HTM concen-
trations higher than 1 μmol · L−1 inhibited clonogenic
growth but nanomolar HTM doses stimulated cell pro-
liferation [14] Within the CTC model, HTM would in-
hibit proliferation of G-cells when both HTM and
gastrin are high but such experiments have not been re-
ported for G-cells.
(iv) Histamine stimulates production of Gastrin by
G-Cells
HTM stimulates release of GAS from G-cells via H2-
receptors, as was previously noted [7].
(3) (i) ECL cells have receptors for Gastrin
ECL cells have receptors for GAS [15], and the mRNA
for the cholecystokinin B/gastrin receptor is present in
ECL cells of the human stomach [16].
(ii) Gastrin stimulates proliferation of ECL Cells
GAS stimulates the proliferation rate of both ECL
cells and of stem cells in the oxyntic mucosal pro-
genitor zone of the rat stomach [17, 18]. GAS also
induces ECL cell proliferation in cell culture [19] and
it has a specific proliferative effect on rat ECL cells
[20]. Amidated gastrin causes increased proliferation
of ECL cells in the oxyntic mucosa of the stomach of
mice [21]. Antrectomy in rats causes atrophy of the
oxyntic gland mucosa [22].
(iii) Gastrin inhibits proliferation of ECL cells when
[GAS] and (HTM] are high
GAS inhibition of ECL cells is not recorded but
GAS does inhibit proliferation of colon cancer cells
[23] although the level of HTM is not known here.
(iv) Gastrin stimulates production of HTM by ECL
Cells
Gastrin stimulates the synthesis of HTM [24, 25] and
GAS stimulates the release of histamine from gastric
ECL cells in cell culture [19] and from rabbit fundic mu-
cosal cells enriched in ECL cells [26]. (That GAS stimu-
lates acid production by parietal cells is independent of
the proposed model.)
(4) The G-cells and ECL cells would each have a re-
ceptor for the gastrin:histamine complex.
GAS has four cell receptors with variable binding to
gastrin variants [1] and one could possibly bind a
gastrin:histamine complex (TCC). Similarly, HTM also
has four (H1, H2, H3 and H4) receptors [2] and one
could possibly bind the TCC.
Overview
In this model, gastrin and histamine are stimulants (Tre-
fones) of the ECL cells and the G-cells, respectively.
Each cell, via the Trefone it produces, has a stimulating
effect on the cell activity and on the cell division of the
couplet cell. For example, gastrin stimulates the activity
of the ECL cells and stimulates the proliferation rate of
both ECL cells and stem cells [17]. An activated ECL cell
becomes a hypertrophic cell within a week of exposure
to high levels of gastrin and the cell division rate is
maximal after about 10 days of hypergastrinemia
[27]. Indeed, the histamine-releasing and the trophic
effects of gastrin may be mediated via the same gas-
trin receptor [18].
With adequate nutrients, each Trefone will initially
stimulate the recipient cells to produce more of the
couplet stimulant and grow in size if necessary. Further,
each cell, sustained with adequate nutrients and other
growth enhancers will gain competence to progress to
cell division and to divide symmetrically or asymmetric-
ally, dependent on the level of the Trefones. In the
current model, whether a cell divides and the type of
division is contingent on the concentration of the gas-
trin:histamine complex. The calculated data relevant to
this contingency is tabulated in Additional File Six of
reference [3]. As an example, if the ECL cell detects a
low level of free gastrin, then the response depends on
the concentration of the complex of gastrin:histamine. A
low, medium or high concentration of complex would
signal underactive, duly active or overactive status of the
ECL cell itself which has produced low, medium and
high levels of total histamine respectively. The cell then
has a measure of the amount of histamine relative to the
amount of gastrin to allow a decision on whether the
two hormones (and their source cells) are in harmony or
not. If there is a sustained imbalance, a cellular decision,
for each cell type, may then be to divide symmetrically,
asymmetrically or with dedifferentiation or with transdif-
ferentiation, as appropriate to bring the G-cells and ECL
cells back into harmony. Apoptosis is also possible [3].
Gastrin can induce apoptosis in gastric epithelial cells
and this contributes to the development of gastric car-
cinogenesis [28].
One possible means by which the cells could measure
the gastrin:histamine complex would be to have cell
membrane receptors for the complex. This is illus-
trated in Fig. 2. The existence of a membrane recep-
tor is not integral to this hypothesis but there needs
to be some intracellular mechanism to measure the
level of complex [3].
Once internalised, a component or a signal derived
from (i) the gastrin, its receptor and/or the couplet com-
plex in ECL cells or (ii) the histamine, its receptor and/
or the couplet complex in G-cells would need to localise
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to the nucleus to affect gene expression and cell
division.
Note that these simple reciprocal interactions are seen
to be just a part of a number of potential cellular inter-
actions that produce the complexity of this gastric area.
The binding of gastrin and histamine to produce a
complex – for investigation
A metal ion may be involved in the binding of gastrin
and histamine.
Zinc forms a complex with histamine and zinc-
histamine-aspartate and zinc-histamine-glutamate com-
plexes are formed with the respective dicarboxylic acids
[29]. Within gastrin (of perhaps 17 amino-acid residues),
there are five glutamate residues, in positions 6 to 10, so
that a zinc complex with histamine and gastrin is con-
ceivable, given that gastrin binds both divalent and triva-
lent metal ions [30]. Further, gastrin forms a ternary
complex with albumin and various metal ions, and the
highest association constant is with zinc [31].
Iron could also be involved in a ternary complex. Fer-
ric ions are essential for the biological activity of gastrin
(glycine-extended) [32]. Indeed, gastrin binds two ferric
ions with high affinity and the glutamate residues of gas-
trin are involved in the binding of both of these atoms
of iron [33]. That it is this ferric complex which is active
as a stimulant to proliferation of colonic mucosa [34],
may need to be considered. In addition, histamine binds
FeIII heme proteins, in particular nitrophorin [35],
wherein an aspartate stabilises the complex [36].
Location of cells and paracrine or endocrine
communication
It is generally considered that the ECL cells have no
close contact with G-cells. The usual description of the
location of these cells is that G-cells are in the antrum
and ECL cells are in the corpus/body of the stomach
(but accepted to be in the lower third of this area close
to the G-cells).
But there is unlikely to be a sharply-defined boundary
between the cells in these areas and there is evidence for
an overlap or mixed zone of ECL cells and G-cells. G-
cells have been mmunocytochemically identified in the
antral zone of the rat [37] and gastrin expression has
been co-localized with the expression of histidine de-
carboxylase, an ECL cell marker, in a subset of histamin-
ergic gastric mucosal cells [38].
Gastrin and histamine could interact with the coupling
cell via a short diffusion if the cells shared a common lo-
cation or by more direct cellular contact possibly via
cytoplasmic processes [39, 40]. Over larger separatory
distances, diffusion directed by microanatomy [41] or ei-
ther microcirculatory or endocrine transport allow inter-
action of the molecules with the cells.
The relationship of this model of gastric function to
Helicobacter pylori
H. pylori could be involved in gastric function in two
ways which are compatible with the proposed model.
One could be by (a) an oncoprotein virulence factor
(CagA), the other by (b) a histamine receptor agonist
(methyl histamine).
(a).One virulence factor of H. pylori is the oncoprotein
cytotoxin-associated antigen A (CagA). Overexpressed
CagA affects various intracellular pathways and is suf-
ficient by itself to induce gastric cancer and other ma-
lignancies in transgenic mice [42].
One mechanism of tumour initiation could involve
the specific interaction of CagA with PAR1/MARK
kinase [43]. This binding inhibits the kinase activity
which is necessary for microtubule stabilisation and
consequent epithelial cell polarity [44] and also
deregulates SHP-2 phosphatase, an oncoprotein
associated with growth regulation and malignancies
[45]. Thus CagA affects polarity and subsequent
intercellular interactions and alters kinase/phosphatase
reactions which could alter cell growth. Gastric
carcinogenesis could be due to abnormal proliferation
of epithelial cells associated with earlier CagA-induced
abnormal intestinal transdifferentiation of cells to
produce intestinal metaplasia as an early stage of
Fig. 2 A Possible Complex Interaction of a G-Cell and an ECL Cell. The reciprocal interactions of a G-Cell and an ECL Cell (GC and ECLC) are illustrated as
in Fig. 1. In addition, this model incorporates a possible extracellular receptor for the Gastrin:Histamine complex (the CC in this particular case)
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gastric cancer [45] In addition, PAR1/MARK kinase is
one of the six par genes necessary for the asymmetric
division of the zygote of C. Elegans [46] and these
protein kinases are evolutionarily conserved from
yeast to humans. If CagA-induced kinase inhibition
prevents asymmetric cell division (AsCD) or causes an
aberrant AsCD, then the homeostasis of the couplet
cells (G-cells and ECL cells) could be disrupted and
abnormal proliferation could ensue. In addition,
epigenetic alterations (DNA methylations and histone
modifications) induced by H. pylori, could contribute
to cancer development [47]. However, although this
relationship between H. pylori infection and gastric
cancer is established, knowledge of the exact
mechanism of tumor initiation is lacking [48].
Within the model proposed here, the mechanism of
metaplasia and cancer would be via abnormal AsCD
of precursor cells producing abnormal types and/or
numbers of G-cells and/or ECL cells. Excess of
histamine and/or gastrin or the presence of aberrant/
mutated receptor molecules or of molecules which
translate the messages of the couplet molecules,
would be part of the mechanism.
(b).In addition to CagA, H. Pylori produces N-alpha-
methyl histamine (NAMH) [49], which stimulates
H3-histamine receptors in gastric mucosa [7, 50]
and which stimulates gastrin release from rabbit
G-cells via H2- histamine receptors [7].
Within the model proposed here, there are two
possibilities:-
(i).If NAMH forms a complex with gastrin, then, with
an unregulated supply of NAMH from H.pylori,
there would be maximal continuous stimulation of
gastrin release and of G-cell proliferation. Because of
the high level of NAMH, there would be little local
free gastrin to stimulate ECL cells. In summary there
would be a large numbers of G-cells but few ECL
cells. The G-cells may be abnormal if the cell divi-
sions, especially transdifferentiations, are affected
by CagA. Gastrin that enters the blood may
stimulate hyperacidity of the stomach via the
parietal cells.
(ii).If NAMH does not form a complex with gastrin,
then there would be a large production of gastrin
initially with an associated strong stimulation of
histamine release and of ECL cell proliferation. But
with a high level of the gastrin:histamine complex,
then both cell types would tend to reduce secretion
and cell division except that the NAMH would still
stimulate the G-cells. Again, CagA may adversely
affect cell divisions and transdifferentiation. Histamine,
released from mast cells recruited by the H. pylori
infection [7], may exacerbate this disturbance from
normal cell divisions.
Conclusion
A model is proposed involving asymmetric cell division
which produces G-cells and ECL cells which communi-
cate to each other via the secreted couplet molecules of
gastrin and histamine. Each will stimulate the cell that it
is not secreted from, to stimulate the other cell to se-
crete more of the couplet molecule and, if this response
is inadequate, to stimulate cell division in order to main-
tain a fixed ratio of gastrin:histamine as assessed by the
level of the complex formed by the couplet molecules.
Abnormal cell division in Helicobacter infection could
be part of the cause of cancer in some cases of this
infection.
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